The Australian Technical Advisory Group on Immunisation (ATAGI) has made the following recommendations about Pneumovax 23:
- A dose of Pneumovax 23 should be given to all adults at 65 years of age
- A second dose (a single revaccination) of Pneumovax 23 is no longer recommended for non-Indigenous adults aged 65 years and over without conditions that predispose them to an increased risk of invasive pneumococcal disease
- A second dose continues to be recommended for those with any of these predisposing conditions
- Recommendations for Aboriginal and Torres Strait Islander people aged <65 years of age are unchanged from the Australian Immunisation Handbook.
Advice about these recommendations is available in the pneumococcal chapter in the Australian Immunisation Handbook and from the Therapeutic Goods Administration (TGA).